Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible — Iztok Hozo (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible
Shared by
John P A Ioannidis
Stanford University
Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible
Article
2022
en
Authors
+1 more
IH
Iztok Hozo
BD
Benjamin Djulbegović
AP
Austin J. Parish
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
There is no upper limit on the maximum effect that can be detected in randomized trials
Benjamin Djulbegović
,
Iztok Hozo
,
Renata Iskander
,
Austin J. Parish
,
Jonathan Kimmelman
,
John P A Ioannidis
Article
2005
Comparison of Large Versus Smaller Randomized Trials for Mental Health-Related Interventions
Despina G. Contopoulos‐Ioannidis
,
Simon Gilbody
,
Thomas A Trikalinos
,
Rachel Churchill
,
Kristian Wahlbeck
,
John P A Ioannidis
Article
2018
Extremely large outlier treatment effects may be a footprint of bias in trials from less developed countries: randomized trials of gabapentinoids
Karishma Desai
,
Ian Carroll
,
Steven M. Asch
,
Tina Hernandez‐Boussard
,
John P A Ioannidis
Article
2025
Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts
Jonathan Henssler
,
Joana Reis‐Pardal
,
Lina Koppel
,
John P A Ioannidis
Preprint
2025
Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts
Jonathan Henssler
,
Joana Reis‐Pardal
,
Lina Koppel
,
John P A Ioannidis
Discussion(0)
No comments yet. Be the first to comment.